학술논문

Switch to EGFR-TKI after upfront platinum doublet induction therapy in non-small cell lung cancer (NSCLC) patients with EGFR (Epidermal Growth Factor Receptor) mutation: A multicentre retrospective study
Document Type
Article
Source
In: Cancer Treatment and Research Communications. (Cancer Treatment and Research Communications, January 2022, 31)
Subject
Language
English
ISSN
24682942